{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:50:24Z","timestamp":1792839024055,"version":"4.5.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>The most important prognostic factor for survival in ovarian cancer patients is complete cytoreduction. The preoperative prediction of suboptimal cytoreduction, considered as any residual disease at the end of surgery, could prevent futile surgery and morbidity. Here, we aimed to identify markers in the preoperative abdominal CT scans of an unselected cohort of patients with ovarian cancer that are predictive of incomplete cytoreduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a single-institution retrospective analysis of 105 epithelial ovarian cancer (EOC) patients treated with surgical cytoreduction between 2010 and 2020. Twenty-two variables on preoperative abdominal CT scans were compared to the intraoperative macroscopic findings by Fisher\u2019s exact test. Parameters with a significant correlation between intraoperative findings and imaging were analyzed by multivariate binary logistic regression analysis regarding the surgical outcome of complete versus incomplete cytoreduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Complete cytoreduction (CC), indicated by the absence of macroscopic residual disease, was achieved in 79 (75.2%) of 105 patients and 46 (63.9%) of 72 International Federation of Gynecology and Obstetrics (FIGO) stage III and IV patients. Twenty patients (19%) were incompletely cytoreduced due to miliary carcinomatosis of the small bowel, and six patients (5.7%) had various locations of residual disease. Thirteen variables showed a significant correlation between imaging and surgical findings. Large-volume ascites, absence of numerically increased small lymph nodes at the mesenteric root, and carcinomatosis of the transverse colon in FIGO stage III and IV patients decreased the rate of CC to 26.7% in the multivariate analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Large-volume ascites, the absence of numerically increased small lymph nodes at the mesenteric root, and carcinomatosis of the transverse colon are markers in preoperative CT scans predicting a low chance for complete cytoreduction in unselected ovarian cancer patients in a real-world setting.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.1060006","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T08:31:55Z","timestamp":1671093115000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Predicting incomplete cytoreduction in patients with advanced ovarian cancer"],"prefix":"10.3389","volume":"12","author":[{"given":"Eva K.","family":"Egger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Antonia","family":"Buchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Recker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias B.","family":"Stope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Mustea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milka","family":"Marinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the arbeitsgemeinschaft gynaekologische onkologie studiengruppe ovarialkarzinom (AGO-OVAR) and the groupe d\u2019Investigateurs nationaux pour les etudes des cancers de l\u2019Ovaire (GINECO)","volume":"115","author":"Bois","year":"2009","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA1911361","article-title":"PAOLA-1 investigators. olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-012-0041-9","article-title":"Bevacizumab in the treatment of ovarian cancer","volume":"29","author":"Heitz","year":"2012","journal-title":"Adv Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol Am Soc Clin Oncol (ASCO);"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: A meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.10.022","article-title":"The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer","volume":"108","author":"Eisenhauer","year":"2008","journal-title":"Gynecol Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21873\/INVIVO.12174","article-title":"Risk factors for severe complications in ovarian cancer surgery","volume":"34","author":"Egger","year":"2020","journal-title":"In Vivo"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/S00330-019-06524-X","article-title":"Diagnostic performance of imaging for the detection of peritoneal metastases: A meta-analysis","volume":"30","author":"van 't Sant","year":"2020","journal-title":"Eur Radiol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/J.YGYNO.2016.03.015","article-title":"Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery","volume":"141","author":"Heitz","year":"2016","journal-title":"Gynecol Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000001173","article-title":"Specific regions, rather than the entire peritoneal carcinosis index, are predictive of complete resection and survival in advanced epithelial ovarian cancer","volume":"28","author":"Rosendahl","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1136\/ijgc-2020-IGCS.18","article-title":"Efficacy of maintenance olaparib plus bevacizumab by biomarker status in clinical higher- and lower-risk patients with newly diagnosed, advanced ovarian cancer in the PAOLA-1 trial","author":"Harter","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_SUPPL.6000","article-title":"Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III\/ENGOT-ov20","volume":"38","author":"Du Bois","year":"2020","journal-title":"JCO"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/J.YGYNO.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/JSO.20049","article-title":"Zoetmulder peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement","volume":"86","author":"de Bree","year":"2004","journal-title":"J Surg Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/S00330-013-3083-8","article-title":"Whole-body MRI with diffusion-weighted sequence for staging of patients with suspected ovarian cancer: a clinical feasibility study in comparison to CT and FDG-PET\/CT","volume":"24","author":"Michielsen","year":"2014","journal-title":"Eur Radiol;"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0B013E3182A616A7","article-title":"Accuracy and reproducibility of the peritoneal cancer index in advanced ovarian cancer during laparoscopy and laparotomy","volume":"23","author":"Gouy","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJSO.2012.01.001","article-title":"Variation in the peritoneal cancer index scores between surgeons and according to when they are determined (before or after cytoreductive surgery)","volume":"38","author":"Elias","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1245\/S10434-008-0234-2","article-title":"Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis","volume":"16","author":"Koh","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/CNCR.20376","article-title":"The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma","volume":"101","author":"Dowdy","year":"2004","journal-title":"Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000000768","article-title":"Peritoneal carcinomatosis in primary ovarian cancer staging: comparison between MDCT, MRI, and 18F-FDG PET\/CT","volume":"40","author":"Schmidt","year":"2015","journal-title":"Clin Nucl Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJSO.2021.03.239","article-title":"Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET\/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer","volume":"47","author":"Mikkelsen","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-73359-9_3","article-title":"Ovarian cancer: Molecular & diagnostic imaging and treatment strategies","volume":"1330","author":"Drakes","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00292-y","article-title":"ARTICLE systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication","volume":"7","author":"Liu","year":"2021","journal-title":"Breast Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221118664","article-title":"Diagnostic significance of mesenteric lymph node involvement in proximal small bowel crohn\u2019s disease","volume":"15","author":"Maconi","year":"2022","journal-title":"Therap Adv Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.673631","article-title":"Clinical phenotypes of tumors invading the rectosigmoid colon affecting the extent of debulking surgery and survival in advanced ovarian cancer","volume":"11","author":"Park","year":"2021","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000368","article-title":"Predicting surgical outcome in patients with international federation of gynecology and obstetrics stage III or IV ovarian cancer using computed tomography: A systematic review of prediction models","volume":"25","author":"Rutten","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer","volume":"25","author":"Axtell","year":"2007","journal-title":"J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJOG.2008.06.052","article-title":"Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma","volume":"199","author":"Fagotti","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/J.YGYNO.2013.08.005","article-title":"Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience","volume":"131","author":"Fagotti","year":"2013","journal-title":"Gynecol Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study","volume":"13","author":"Fagotti A","year":"2006","journal-title":". Ann Surg Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/IJGC-2020-001718","article-title":"Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer","volume":"31","author":"Fleming","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"8111","DOI":"10.1038\/S41598-021-86928-2","article-title":"MUAPOS working group (Multidisciplinary unit of abdominal pelvic oncology surgery) validation of three predictive models for suboptimal cytoreductive surgery in advanced ovarian cancer","volume":"11","author":"Llueca","year":"2021","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/J.SURONC.2016.07.001","article-title":"Is complete cytoreductive surgery feasible in this patient with ovarian cancer","volume":"25","author":"Dessapt","year":"2016","journal-title":"Surg Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13048-018-0415-y","article-title":"A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: A two-centers experience","volume":"11","author":"Ghisoni","year":"2018","journal-title":"J Ovarian Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1060006\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T08:31:57Z","timestamp":1671093117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.1060006\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":36,"alternative-id":["10.3389\/fonc.2022.1060006"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.1060006","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"article-number":"1060006"}}